December 2021 - Page 2 of 4 - BioMedWire (BMW)

MondayDec 20, 2021 12:13 pm

RYAH Group Inc. (CSE: RYAH) Releases Medical Cannabis Report on Cancer and Adverse Cancer Treatment Effects

RYAH recently released report highlighting medical cannabis treatment for cancer and adverse effects of cancer treatment Data from 80,000 sessions logged between January 1, 2018 and November 15, 2021 tracked conditions including anxiety, cachexia, fatigue, pain, nausea, and stress 62% of patients reported a moderate experience using cannabis to treat cancer-related conditions RYAH supports cancer research and treatment with IoT product ecosystem comprised of volume-control devices, medicine-carrying components, mobile applications RYAH Group (CSE: RYAH), the leader in volume-control technology for plant-based medicine, recently released a medical cannabis report on cancer and the adverse effects of cancer treatment (https://ibn.fm/Es52b). Data from…

MondayDec 20, 2021 11:53 am

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA), an Undervalued Opportunity for Investment

Mydecine’s and CMPS’ stocks have been grossly undervalued largely due to a lack of understanding of the psychedelic space The situation presents a unique opportunity for investment, as Roth Capital Partners issued a $3 buy rating for 2022 Mydecine has put systems and infrastructure in place to bank on the growing PTSD treatment, smoking cessation, and the health and wellness apps market, in its drive to increase value for its shareholders There has been a huge misunderstanding of the psychedelic space and the potential that this industry has, specifically regarding the treatment of Post-Traumatic Stress Disorder (“PTSD”) and smoking cessation.…

MondayDec 20, 2021 9:38 am

Understanding Prostate Cancer’s Early Warning Signs

Estimates show that nearly 200,000 Americans are diagnosed with prostate cancer annually, making it one of the most commonly diagnosed cancers after breast and lung cancer. The survival rate for this particular cancer is high, especially if diagnosed in its early stages. Figures show that when this cancer is diagnosed before it metastasizes, roughly 97% of individuals live at least five years after diagnosis. However, most individuals with prostate cancer don’t display any symptoms or signs, especially when the disease is still in its early stages. This is why it’s important to know some of the signs of prostate cancer,…

FridayDec 17, 2021 2:00 pm

Study Finds CBD Cigarettes Decrease Use of Antipsychotic Medications

CBD cigarettes are cigarettes manufactured from hemp instead of tobacco. The cigarettes contain CBD and a small amount of THC. CBD is a nonpsychoactive compound found in cannabis while THC is the psychoactive compound that induces a high. Data from a new trial has found that the use of CBD cigarettes is linked to a decrease in patients’ use of antipsychotic drugs. The cigarettes’ effects usually last two to three hours and take between a few seconds and some minutes to set in. This mode of consumption makes it the fastest way to feel CBD’s effects. The placebo-controlled trial was…

ThursdayDec 16, 2021 12:00 pm

Yale Studies Could Lead to Improved Treatment of Cancer

Two new studies led by researchers from Yale have discovered new information about the ALK receptor (anaplastic lymphoma kinase molecule) and the role it plays in cancer formation. The studies have made progress in determining ALK’s structure status as a receptor protein. Their findings were published in “Nature.” The codirector of the Cancer Biology Institute, Joseph Schlessinger, is a senior author of one of the studies. Yale School of Medicine assistant professor of pharmacology Daryl Klein is the senior author of the second study. A postdoctoral associate in Klein’s laboratory, Tongqing Li, stated that ALK was one of the receptor…

WednesdayDec 15, 2021 11:06 am

Drug Addiction: The US Searches for Novel Ways to Prevent Overdoses

Opioids are a class of drugs made from the opium poppy plant. These drugs work in the brain to produce various effects, including pain relief. Opioids are usually given as prescription medications to treat moderate to severe pain. However, long-term use of the drugs increases an individual’s dependence and tolerance, which results in higher and more frequent doses and sometimes addiction. In 2019, almost 50,000 individuals in the United States died from opioid-related overdoses. This number has steadily increased since then, with the most recent figures showing that 100,000 people have died because of overdoses associated with fentanyl in the…

TuesdayDec 14, 2021 11:32 am

Review Finds Aerobic Exercise Benefits Fibromyalgia Patients

A review published in the “Cochrane Library” stated that aerobic exercise may be beneficial to patients suffering from fibromyalgia. Aerobic exercises such as swimming and walking are known to improve cardiovascular conditioning, in addition to other benefits. These include helping control weight and blood sugar, lowering an individual’s blood pressure, improving circulation and strengthening the heart. The systematic literature review was conducted by researchers from the Norwegian Institute of Public Health in Oslo, led by Julia Bidonde. Fibromyalgia is a disorder characterized by musculoskeletal pain that is normally accompanied by mood and memory issues, sleep issues and fatigue. Experts believe…

MondayDec 13, 2021 9:56 am

Pandemic Exposes Extent of Kids’ Mental Health Issues

The coronavirus pandemic has not only affected economies around the globe but also impacted the mental health of both grown-ups and children significantly. Behavioral disorders, anxiety and depression are among the leading causes of disability and illness among adolescents. Data from the World Health Organization (“WHO”) shows that one in every seven children between the ages of 10 to 19 experiences a mental disorder, which makes up about 13% of the worldwide burden of illness. Adolescents with mental health issues are especially vulnerable to risk-taking behaviors, educational difficulties, stigma, discrimination and social exclusion. Harvard professor Karestan Koenen notes that the…

FridayDec 10, 2021 12:58 pm

Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) Discusses Psychedelics Research, Life Sciences Focus, at Key Industry Conferences

MINDCURE President and CEO Kelsey Ramsden will participate in, and has already attended multiple industry conferences throughout December Participation in #CanndoraConnect: Women in Psychedelics Conference focused on exploring job opportunities in psychedelics Company remains focused on promoting healing and improving mental health via digital therapeutics technology and psychedelic compounds research Company reports that 971 million people worldwide suffer from a mental disorder. As of 2019, MINDCURE calculates that 12,472 registered mental health facilities treatment facilities could benefit from the company’s proprietary digital therapeutics technology, iSTRYM The global digital therapeutics market is valued at $3.4 billion and is projected to reach…

FridayDec 10, 2021 9:33 am

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) New Patent Application Offering Improved Delivery Control, Enhanced Shelf Stability, of Psilocin

The full patent application covers multiple families of psilocin analogs. Psilocin is the active metabolite of psilocybin In addition to improving delivery control, the company’s dermal application route can potentially eliminate undesirable side effects such as nausea Mydecine appoints Dr. Saeid Babaei, PhD, as an independent board member. The appointment can help advance the company’s NASDAQ listing efforts, bringing decades of experience in biotech development and licensing and strategic advancements Company intends to uplist to NASDAQ in Q1 2022 Improving delivery control and shelf stabilization of psilocybin’s active metabolite psilocin, two critical aspects for use in medical settings, is the…